Young Min OH
Inventor
Stats
- 1 US patents issued
- 15 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 1 US Patents Issued
- 15 US Applications Filed
- 40 Total Citation Count
- Aug 24, 2023 Most Recent Filing
- Feb 28, 2001 Earliest Filing
Work History
Patent Owner | Applications Filed | Year |
---|---|---|
KOREA INSTITUTE OF GEOSCIENCE AND MINERAL RESOURCES | 1
1 | 2012
2014 |
SALMON LICENSING LLC | 1
| 2001
|
CATHOLIC UNIVERSITY INDUSTRY ACADEMIC COOPERATION FOUNDATION | 1
| 2013
|
KOREA INSTITUTE OF GEOSCIENCE AND MINERAL RESOURCES (KIGAM) | 1
| 2012
|
KT CORPORATION | 1
| 2004
|
KIA MOTORS CORPORATION | 1
| 2003
|
KOREA TELECOM | 1
| 2001
|
SAMSUNG SDI CO., LTD. | 1
| 2016
|
Inventor Addresses
Address | Duration |
---|---|
Anyang-city, KR | Aug 29, 02 - Aug 29, 02 |
Busan Metropolitan City, KR | Apr 21, 05 - Apr 21, 05 |
Daejeon, KR | May 03, 18 - Feb 05, 19 |
Goyang, KR | May 06, 21 - Oct 18, 22 |
Goyang-si, KR | Dec 20, 12 - Mar 24, 15 |
Gyeonggi-do, KR | Mar 03, 16 - Apr 21, 16 |
Seongnam-city, KR | Dec 08, 05 - Dec 08, 05 |
Seoul, KR | Jan 23, 25 - Mar 27, 25 |
Yongin-si Gyeonggi-do, KR | Aug 17, 23 - Nov 09, 23 |
Yongin-si, KR | Jan 26, 17 - Apr 27, 23 |
Technology Profile
Technology | Matters | |
---|---|---|
A61G: | TRANSPORT, PERSONAL CONVEYANCES, OR ACCOMMODATION SPECIALLY ADAPTED FOR PATIENTS OR DISABLED PERSONS | 1 |
A61K: | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | 2 |
A61P: | THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS | 2 |
Patents / Publication
Patents / Publication # | Year of Publication / Issued | Title | Citations |
---|---|---|---|
2025/0099,548 | 2025 | PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING DEGENERATIVE BRAIN DISEASES, CONTAINING GLUCAGON-LIKE PEPTIDE-1 AND INTERLEUKIN-1 RECEPTOR ANTAGONIST | 0 |
2025/0028,959 | 2025 | DEVICE AND METHOD FOR SEARCHING NEURAL NETWORK ARCHITECTURE USING SUPERNET | 0 |
2023/0357,346 | 2023 | FUSION PROTEIN INCLUDING GLUCAGON-LIKE PEPTIDE-1 AND INTERLEUKIN-1 RECEPTOR ANTAGONIST AND USE THEREOF | 0 |
2023/0279,124 | 2023 | FUSION PROTEIN COMPRISING IGE FC RECEPTOR ALPHA SUBUNIT EXTRACELLULAR DOMAIN AND ANTI-IL-4R ANTIBODY, AND USE THEREOF | 0 |
2023/0257,438 | 2023 | FUSION PROTEIN COMPRISING ANTI-LAG-3 ANTIBODY AND IL-2, AND USE THEREOF | 0 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.